{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T14:14:11Z","timestamp":1790691251422,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.imlet.2021.06.009","type":"journal-article","created":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T06:04:22Z","timestamp":1628143462000},"page":"1-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["The crosstalk between H. pylori virulence factors and the PD1:PD-L1 immune checkpoint inhibitors in progression to gastric cancer"],"prefix":"10.1016","volume":"239","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4548-5227","authenticated-orcid":false,"given":"Elif Merve","family":"Ayd\u0131n","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8180-5761","authenticated-orcid":false,"given":"Tevriz Dilan","family":"Demir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2379-5542","authenticated-orcid":false,"given":"Nogayhan","family":"Seymen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sawsan Sudqi","family":"Said","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2255-0930","authenticated-orcid":false,"given":"Sinem","family":"Oktem-Okullu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arzu","family":"Tiftikci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahattin","family":"Cicek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma","family":"Tokat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nurdan","family":"Tozun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umit","family":"Ince","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ugur","family":"Sezerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9015-8244","authenticated-orcid":false,"given":"Ayca","family":"Sayi-Yazgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.imlet.2021.06.009_bib0001","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"issue":"4","key":"10.1016\/j.imlet.2021.06.009_bib0002","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1128\/CMR.00011-10","article-title":"Helicobacter pylori and gastric cancer: factors that modulate disease risk","volume":"23","author":"Wroblewski","year":"2010","journal-title":"Clin. Microbiol. Rev."},{"issue":"13","key":"10.1016\/j.imlet.2021.06.009_bib0003","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1007\/s00018-019-03044-1","article-title":"Helicobacter pylori infection and gastric cancer biology: tempering a double-edged sword","volume":"76","author":"Mentis","year":"2019","journal-title":"Cell. Mol. Life Sci."},{"issue":"1","key":"10.1016\/j.imlet.2021.06.009_bib0004","doi-asserted-by":"crossref","DOI":"10.3390\/cells10010027","article-title":"Helicobacter pylori Virulence Factors-Mechanisms of Bacterial Pathogenicity in the Gastric Microenvironment","volume":"10","author":"Baj","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.imlet.2021.06.009_bib0005","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.3389\/fmicb.2017.01883","article-title":"A New Role for Helicobacter pylori Urease: Contributions to Angiogenesis","volume":"8","author":"Olivera-Severo","year":"2017","journal-title":"Front Microbiol"},{"issue":"8","key":"10.1016\/j.imlet.2021.06.009_bib0006","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0136212","article-title":"Multiplex-PCR-Based Screening and Computational Modeling of Virulence Factors and T-Cell Mediated Immunity in Helicobacter pylori Infections for Accurate Clinical Diagnosis","volume":"10","author":"Oktem-Okullu","year":"2015","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.imlet.2021.06.009_bib0007","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1097\/MEG.0b013e328364b53e","article-title":"Helicobacter pylori CagA and VacA genotypes and gastric phenotype: a meta-analysis","volume":"25","author":"Matos","year":"2013","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.imlet.2021.06.009_bib0008","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1365-2958.1996.tb02612.x","article-title":"The vacuolating cytotoxin of Helicobacter pylori","volume":"20","author":"Cover","year":"1996","journal-title":"Mol. Microbiol."},{"issue":"30","key":"10.1016\/j.imlet.2021.06.009_bib0009","doi-asserted-by":"crossref","first-page":"17771","DOI":"10.1074\/jbc.270.30.17771","article-title":"Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration","volume":"270","author":"Atherton","year":"1995","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.imlet.2021.06.009_bib0010","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1038\/ajg.2011.1","article-title":"Helicobacter pylori cagA and vacA genotypes as predictors of progression of gastric preneoplastic lesions: a long-term follow-up in a high-risk area in Spain","volume":"106","author":"Gonzalez","year":"2011","journal-title":"Am. J. Gastroenterol."},{"issue":"23","key":"10.1016\/j.imlet.2021.06.009_bib0011","doi-asserted-by":"crossref","first-page":"6126","DOI":"10.1128\/JB.01081-10","article-title":"Molecular evolution of the Helicobacter pylori vacuolating toxin gene vacA","volume":"192","author":"Gangwer","year":"2010","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.imlet.2021.06.009_bib0012","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/426309","article-title":"H. pylori virulence factors: influence on immune system and pathology","author":"Kalali","year":"2014","journal-title":"Mediators Inflamm."},{"issue":"2","key":"10.1016\/j.imlet.2021.06.009_bib0013","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1574-695X.2007.00258.x","article-title":"The neutrophil-activating protein of Helicobacter pylori (HP-NAP) as an immune modulating agent","volume":"50","author":"D'Elios","year":"2007","journal-title":"FEMS Immunol. Med. Microbiol."},{"issue":"1","key":"10.1016\/j.imlet.2021.06.009_bib0014","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.bj.2015.06.002","article-title":"Helicobacter pylori infection: An overview of bacterial virulence factors and pathogenesis","volume":"39","author":"Kao","year":"2016","journal-title":"Biomed J"},{"issue":"1","key":"10.1016\/j.imlet.2021.06.009_bib0015","doi-asserted-by":"crossref","first-page":"6435","DOI":"10.1038\/s41598-018-24879-x","article-title":"Production and delivery of Helicobacter pylori NapA in Lactococcus lactis and its protective efficacy and immune modulatory activity","volume":"8","author":"Peng","year":"2018","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.imlet.2021.06.009_bib0016","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.4049\/jimmunol.1400339","article-title":"Vector-encoded Helicobacter pylori neutrophil-activating protein promotes maturation of dendritic cells with Th1 polarization and improved migration","volume":"193","author":"Ramachandran","year":"2014","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.imlet.2021.06.009_bib0017","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s10529-017-2502-3","article-title":"Delivery of Helicobacter pylori HpaA to gastrointestinal mucosal immune sites using Lactococcus lactis and its immune efficacy in mice","volume":"40","author":"Zhang","year":"2018","journal-title":"Biotechnol. Lett."},{"issue":"12","key":"10.1016\/j.imlet.2021.06.009_bib0018","doi-asserted-by":"crossref","first-page":"6977","DOI":"10.4049\/jimmunol.169.12.6977","article-title":"Protection against Helicobacter pylori infection following immunization is IL-12-dependent and mediated by Th1 cells","volume":"169","author":"Akhiani","year":"2002","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.imlet.2021.06.009_bib0019","doi-asserted-by":"crossref","first-page":"962","DOI":"10.4049\/jimmunol.158.2.962","article-title":"T helper 1 effector cells specific for Helicobacter pylori in the gastric antrum of patients with peptic ulcer disease","volume":"158","author":"D'Elios","year":"1997","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.imlet.2021.06.009_bib0020","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2174\/187153012799278974","article-title":"Immune modulation by regulatory T cells in Helicobacter pylori-associated diseases","volume":"12","author":"Raghavan","year":"2012","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"5","key":"10.1016\/j.imlet.2021.06.009_bib0021","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.4049\/jimmunol.176.5.3000","article-title":"Expression of B7-H1 on gastric epithelial cells: its potential role in regulating T cells during Helicobacter pylori infection","volume":"176","author":"Das","year":"2006","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.imlet.2021.06.009_bib0022","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/j.1365-2249.2010.04217.x","article-title":"Increased programmed death-ligand-1 expression in human gastric epithelial cells in Helicobacter pylori infection","volume":"161","author":"Wu","year":"2010","journal-title":"Clin. Exp. Immunol."},{"issue":"1","key":"10.1016\/j.imlet.2021.06.009_bib0023","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007468","article-title":"Increased Programmed Death-Ligand 1 is an Early Epithelial Cell Response to Helicobacter pylori Infection","volume":"15","author":"Holokai","year":"2019","journal-title":"PLoS Pathog."},{"issue":"1","key":"10.1016\/j.imlet.2021.06.009_bib0024","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.pbj.2016.03.004","article-title":"The PD-1:PD-L1 immune inhibitory checkpoint in Helicobacter pylori infection and gastric cancer: a comprehensive review and future perspectives","volume":"1","author":"Silva","year":"2016","journal-title":"Porto Biomed J"},{"issue":"1","key":"10.1016\/j.imlet.2021.06.009_bib0025","first-page":"107","article-title":"Highly Activated PD-1\/PD-L1 Pathway in Gastric Cancer with PD-L1 Expression","volume":"38","author":"Saito","year":"2018","journal-title":"Anticancer Res."},{"key":"10.1016\/j.imlet.2021.06.009_bib0026","doi-asserted-by":"crossref","first-page":"136","DOI":"10.3389\/fonc.2019.00136","article-title":"Expression of PD-L1 and PD-1 in Chemoradiotherapy-Naive Esophageal and Gastric Adenocarcinoma: Relationship With Mismatch Repair Status and Survival","volume":"9","author":"Svensson","year":"2019","journal-title":"Front. Oncol."},{"issue":"4","key":"10.1016\/j.imlet.2021.06.009_bib0027","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1365-2559.1994.tb01349.x","article-title":"Observer variation in the assessment of chronic gastritis according to the Sydney system","volume":"25","author":"Andrew","year":"1994","journal-title":"Histopathology"},{"issue":"1","key":"10.1016\/j.imlet.2021.06.009_bib0028","first-page":"15","article-title":"Doxorubicin inhibits miR-140 expression and upregulates PD-L1 expression in HCT116 cells, opposite to its effects on MDA-MB-231 cells","volume":"44","author":"Naba","year":"2020","journal-title":"Turk J Biol"},{"issue":"6","key":"10.1016\/j.imlet.2021.06.009_bib0029","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.3748\/wjg.v9.i6.1370","article-title":"In situ expression and significance of B7 costimulatory molecules within tissues of human gastric carcinoma","volume":"9","author":"Chen","year":"2003","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.imlet.2021.06.009_bib0030","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.cyto.2017.06.013","article-title":"Gastric expression of IL-17A and IFNgamma in Helicobacter pylori infected individuals is related to symptoms","volume":"99","author":"Adamsson","year":"2017","journal-title":"Cytokine"},{"issue":"9","key":"10.1016\/j.imlet.2021.06.009_bib0031","doi-asserted-by":"crossref","first-page":"5121","DOI":"10.4049\/jimmunol.0901115","article-title":"Helicobacter pylori-induced Th17 responses modulate Th1 cell responses, benefit bacterial growth, and contribute to pathology in mice","volume":"184","author":"Shi","year":"2010","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.imlet.2021.06.009_bib0032","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.18632\/oncotarget.6492","article-title":"Regulatory T cells may participate in Helicobacter pylori persistence in gastric MALT lymphoma: lessons from an animal model","volume":"7","author":"Laur","year":"2016","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.imlet.2021.06.009_bib0033","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.yexmp.2014.03.005","article-title":"Correlation between infiltration of FOXP3+ regulatory T cells and expression of B7-H1 in the tumor tissues of gastric cancer","volume":"96","author":"Hou","year":"2014","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.imlet.2021.06.009_bib0034","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.micres.2018.09.011","article-title":"Helicobacter pylori evasion strategies of the host innate and adaptive immune responses to survive and develop gastrointestinal diseases","volume":"218","author":"Karkhah","year":"2019","journal-title":"Microbiol. Res."},{"issue":"2","key":"10.1016\/j.imlet.2021.06.009_bib0035","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1128\/IAI.00228-06","article-title":"Chronic exposure to Helicobacter pylori impairs dendritic cell function and inhibits Th1 development","volume":"75","author":"Mitchell","year":"2007","journal-title":"Infect. Immun."},{"issue":"7","key":"10.1016\/j.imlet.2021.06.009_bib0036","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1128\/CVI.00422-10","article-title":"Expression of CD25(high) regulatory T cells and PD-1 in gastric infiltrating CD4(+) T lymphocytes in patients with Helicobacter pylori infection","volume":"18","author":"Wu","year":"2011","journal-title":"Clin. Vaccine Immunol."},{"issue":"8","key":"10.1016\/j.imlet.2021.06.009_bib0037","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0182692","article-title":"PD-L1 and gastric cancer prognosis: A systematic review and meta-analysis","volume":"12","author":"Gu","year":"2017","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.imlet.2021.06.009_bib0038","first-page":"1093","article-title":"Role of regulatory T-cells in H. pylori-induced gastritis and gastric cancer","volume":"30","author":"Kandulski","year":"2010","journal-title":"Anticancer Res."},{"issue":"4","key":"10.1016\/j.imlet.2021.06.009_bib0039","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.arcmed.2016.07.013","article-title":"Role of Regulatory T-cells in Different Clinical Expressions of Helicobacter pylori Infection","volume":"47","author":"Bagheri","year":"2016","journal-title":"Arch. Med. Res."},{"issue":"4","key":"10.1016\/j.imlet.2021.06.009_bib0040","first-page":"812","volume":"48","author":"Thorsson","year":"2018","journal-title":"The Immune Landscape of Cancer, Immunity"},{"issue":"3","key":"10.1016\/j.imlet.2021.06.009_bib0041","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1172\/JCI36604","article-title":"PD-L1 negatively regulates CD4+CD25+Foxp3+ Tregs by limiting STAT-5 phosphorylation in patients chronically infected with HCV","volume":"119","author":"Franceschini","year":"2009","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.imlet.2021.06.009_bib0042","article-title":"Associations Between CagA, VacA, and the Clinical Outcomes of Helicobacter Pylori Infections in Okinawa, Japan","volume":"63","author":"Inagaki","year":"2017","journal-title":"Kobe J. Med. Sci."},{"issue":"1","key":"10.1016\/j.imlet.2021.06.009_bib0043","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1757-4749-1-5","article-title":"The prevalence of the duodenal ulcer promoting gene (dupA) in Helicobacter pylori isolates varies by ethnic group and is not universally associated with disease development: a case-control study","volume":"1","author":"Schmidt","year":"2009","journal-title":"Gut Pathog"},{"issue":"14","key":"10.1016\/j.imlet.2021.06.009_bib0044","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1016\/j.vaccine.2006.12.026","article-title":"Oral immunization with HpaA affords therapeutic protective immunity against H. pylori that is reflected by specific mucosal immune responses","volume":"25","author":"Nystrom","year":"2007","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.imlet.2021.06.009_bib0045","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.vaccine.2010.11.088","article-title":"A truncated form of HpaA is a promising antigen for use in a vaccine against Helicobacter pylori","volume":"29","author":"Flach","year":"2011","journal-title":"Vaccine"}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016524782100119X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016524782100119X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T07:39:06Z","timestamp":1759045146000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016524782100119X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":45,"alternative-id":["S016524782100119X"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2021.06.009","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The crosstalk between H. pylori virulence factors and the PD1:PD-L1 immune checkpoint inhibitors in progression to gastric cancer","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2021.06.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}